Liquidia (LQDA) Cash from Operations Growth (1y) (2021 - 2026)
Liquidia (LQDA) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 61.90% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -22.14% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 0.46% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 125.00% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 425.00% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -267.74% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 16.33% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -18.09% |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 272.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 272.72% |
| Dec 31, 2025 | 312.58% |
| Sep 30, 2025 | 61.05% |
| Jun 30, 2025 | -74.22% |
| Mar 31, 2025 | -23.38% |
| Dec 31, 2024 | -30.23% |
| Sep 30, 2024 | -116.95% |
| Jun 30, 2024 | -307.28% |
| Mar 31, 2024 | -194.03% |
| Dec 31, 2023 | -247.21% |
| Sep 30, 2023 | -100.23% |
| Jun 30, 2023 | 33.99% |
| Mar 31, 2023 | 13.55% |
| Dec 31, 2022 | 39.11% |
| Sep 30, 2022 | 0.98% |
| Jun 30, 2022 | -2.06% |
| Mar 31, 2022 | 21.02% |
| Dec 31, 2021 | 46.34% |
| Sep 30, 2021 | 53.39% |
| Jun 30, 2021 | 37.00% |